Add BrightSurf on Google Email

ECOG-ACRIN research at ASCO 2024

The ECOG-ACRIN Cancer Research Group will present late-breaking findings on prostate cancer, breast cancer, and pancreas cancer at ASCO 2024. These studies include optimal chemotherapy for Black women with breast cancer and results from the first randomized national trial in older adults with pancreas cancer.

New findings in JNCCN illustrate pathway for screening high-risk individuals for pancreatic cancer in PRECEDE study

The PRECEDE study found that nearly 80% of participants in the highest-risk cohort completed baseline imaging, highlighting the feasibility of improving early detection and prevention for pancreatic cancer. Researchers recommend sorting individuals into three groups based on family history and genetic mutations to tailor surveillance.

SourceNational Comprehensive Cancer Network·JournalJournal of the National Comprehensive Cancer Network·DateApr 16, 2024

Immune response to investigational RNA vaccine for pancreatic cancer continues to correlate with clinical benefit

Researchers found that an individualized neoantigen-specific mRNA vaccine, autogene cevumeran, can induce a robust immune response in patients with resectable pancreatic cancer. After a median follow-up of three years, the treatment was associated with a significantly longer median recurrence-free survival compared to those who did not...

AACR: Preliminary study finds immunotherapy combination before surgery improves outcomes for patients with pancreatic cancer

A pilot study by UCLA Health investigators suggests that treating patients with immunotherapy and chemotherapy before surgery may improve long-term outcomes for those with borderline resectable pancreatic cancer. The study found a higher rate of successful tumor removal and increased overall survival when compared to historical controls.

Less is more: Not placing a drain improves distal pancreatectomy outcomes

A study published in Lancet Gastroenterology & Hepatology found that not placing a drain during distal pancreatectomy surgery improves patient outcomes. The study, involving 282 patients across ten Dutch and two Italian hospitals, demonstrated a significant reduction in postoperative pancreatic leaks and overall morbidity.

SourceAmsterdam University Medical Center·JournalThe Lancet Gastroenterology & Hepatology·TypeRandomized controlled/clinical trial·DateMar 15, 2024

A step towards clinic-ready patient-derived organoids

A recent study at Salk Institute evaluates the reliability of patient-derived organoids as a clinical model for pancreatic cancer. The findings reveal that organoids' gene expression and drug responses are not affected by commercial extracellular matrix brands, but one product increases growth rate.

SourceSalk Institute·JournalJCI Insight·TypeExperimental study·DateMar 6, 2024

Pancreatic cancer lives on mucus

Researchers at Cold Spring Harbor Laboratory have uncovered a mechanism involved in pancreatic cancer transformation, discovering that low-grade pancreatic cancer cells depend on mucus to survive and thrive. This knowledge could help set the stage for future diagnostic or therapeutic strategies.

UCLA-led research results in FDA approval of 4-drug combination for frontline treatment of metastatic pancreatic cancer

A four-drug chemotherapy regimen, NALIRIFOX, has been approved by the FDA for frontline treatment of metastatic pancreatic adenocarcinoma. The regimen, combining irinotecan liposome, oxaliplatin, leucovorin, and fluorouracil, resulted in longer overall survival compared to a two-drug protocol.

Genetic and therapeutic landscapes in cohort of pancreatic adenocarcinomas using NGS and machine learning

A study published in Oncotarget has identified specific mutational and therapeutic landscapes of pancreatic cancer in the Russian population. By applying machine learning models to full exome individual data, researchers received personalized recommendations for targeted treatment options for each clinical case.

SourceImpact Journals LLC·JournalOncotarget·TypeExperimental study·DateFeb 14, 2024

Obesity and alcohol are contributing to increases in bowel cancer rates among young adults

Experts predict a significant increase in bowel cancer death rates among young adults in the EU and UK, driven by rising obesity and heavy alcohol consumption. Death rates are predicted to rise by 26% in men and nearly 39% in women in the UK, with similar increases seen in Italy and other European countries.

SourceEuropean Society for Medical Oncology·JournalAnnals of Oncology·TypeData/statistical analysis·DateJan 28, 2024

New combination improves radiation therapy outcomes in patients with locally advanced and borderline resectable pancreatic cancer

Researchers developed a new radiation therapy approach combining a sensitizing drug with stereotactic body radiation therapy, resulting in higher progression-free survival and overall response rates. The treatment reduced toxicity while increasing its effectiveness in treating locally advanced pancreatic cancer.

SourceUniversity of Texas M. D. Anderson Cancer Center·JournalThe Lancet Oncology·TypeRandomized controlled/clinical trial·DateNov 28, 2023

Some increase in cancer after 1986 Chernobyl disaster

A long-term study published in Environmental Epidemiology shows a slightly increased incidence of cancer, particularly colon, pancreas, and stomach cancer in men, as well as lymphoma in women. The researchers used new calculation methods to analyze radiation doses from Chernobyl fallout.

SourceUppsala University·JournalEnvironmental Epidemiology·TypeObservational study·DateNov 13, 2023